Article info

Download PDFPDF
Neoadjuvant Chemotherapy Cannot Be Regarded as Adequate Routine Therapy Strategy of Advanced Ovarian Cancer

Authors

  1. Address correspondence and reprint requests to Andreas du Bois, PhD, MD, Chairman, Department of Gynecology & Gynecologic Oncology, Kliniken Essen Mitte (KEM), Henricistrasse 92, Essen, Germany. E-mail: Prof.duBois{at}googlemail.com.

Citation

du Bois A, Marth C, Pfisterer J, et al
Neoadjuvant Chemotherapy Cannot Be Regarded as Adequate Routine Therapy Strategy of Advanced Ovarian Cancer

Publication history

  • Received February 3, 2011
  • First published August 1, 2011.
Online issue publication 
February 26, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.